BackAVEO Pharmaceuticals Overview

AVEO Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for AVEO.

Quarterly SG&A Expenses

$17.58M
↑ 16.09% YoY

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$67.64M
↑ 24.87% YoY

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin